Fortress Biotech (FBIO) Change in Account Payables (2010 - 2020)
Fortress Biotech (FBIO) posted quarterly Change in Account Payables of -$19000.0 for Q4 2020, down 246.15% quarter-over-quarter from $13000.0 in Q1 2020.
Powered by 
Analysis
Fortress Biotech (FBIO) Change in Account Payables (2010 - 2020) Analysis & Trends
Fortress Biotech's Change in Account Payables history runs 7 years deep, the most recent figure standing at -$19000.0 for Q4 2020.
- In Q4 2020, Change in Account Payables changed N/A year-over-year to -$19000.0; the TTM figure through Mar 2021 stood at -$6000.0 (up 97.77% YoY), while the FY2019 annual figure was -$149000.0, down 547.83% from the prior year.
- Change in Account Payables for Q4 2020 stood at -$19000.0, down from $13000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $133000.0 in Q1 2019, with the low at -$298000.0 in Q3 2019.
- The 4-year median for Change in Account Payables is $14500.0 (2019), against an average of -$500.0.
- Peak annual rise in Change in Account Payables reached 1700.0% in 2019, while the deepest fall reached 472.5% in 2019.
- Fortress Biotech's Change in Account Payables stood at $88000.0 in 2017, then plunged by 104.55% to -$4000.0 in 2018, then slumped by 7350.0% to -$298000.0 in 2019, then surged by 93.62% to -$19000.0 in 2020.
- Business Quant data shows FBIO's Change in Account Payables at -$19000.0 in Q4 2020, $13000.0 in Q1 2020, and -$298000.0 in Q3 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | - |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | -19,000.00 |
| Mar 31, 2020 | 13,000.00 |
| Sep 30, 2019 | -298,000.00 |
| Jun 30, 2019 | 16,000.00 |
| Mar 31, 2019 | 133,000.00 |
| Dec 31, 2018 | -4,000.00 |
| Sep 30, 2018 | 80,000.00 |
| Jun 30, 2018 | -1,000.00 |
| Mar 31, 2018 | -98,000.00 |
| Dec 31, 2017 | 88,000.00 |
| Sep 30, 2017 | 60,000.00 |
| Jun 30, 2017 | 24,000.00 |
| Mar 31, 2014 | -398,000.00 |
| Dec 31, 2011 | -48,000.00 |
| Dec 31, 2010 | 5,000.00 |